Microvision Announces New Engineering VP and CFO.

REDMOND, Wash. -- Experienced GE Engineering Manager, Sid Madhavan, joins as VP of Research and Product Development; Jeff T. Wilson promoted to Chief Financial Officer

Microvision, Inc. (Nasdaq:MVIS), announced today that Sid Madhavan, 39, will join the company as Vice President of Research and Product Development and that Jeff T. Wilson, 45, currently Vice President of Accounting has been promoted to Chief Financial Officer.

"Sid is a talented and tireless engineering leader who brings a wealth of cross-functional product development experience, systems and software expertise, platform development and global teams development skills. These skills will accelerate the development of our Integrated Photonics Module (IPM) platform that will serve as an enabler of many high definition display and imaging products," said Microvision President & CEO Alexander Tokman. "During his distinguished GE career, Sid has consistently delivered outstanding results and we are delighted to add him and his skills to our reinvigorated leadership team."

Mr. Madhavan, a certified Six Sigma Black Belt, brings over fifteen years of engineering development and management experience and has a proven track record for leading the definition and development of several key technology platform strategies that he translated into product launches. Mr. Madhavan joins Microvision from GE Healthcare where most recently he served as an Engineering Subsystem Manager for a $2.1 billion Molecular Imaging and Computer Tomography business. He led the core subsystem platform strategy and development effort on the world's first 64 slice LightSpeed Volume CT and state of the art Discovery PET/CT products.. Mr. Madhavan received his B.S. degree in Electronics and Communications from Madurai Kamaraj University in India and his M.S. in Electrical Engineering from Texas A&M.

Mr. Wilson brings over twenty years of experience as a financial professional to the CFO position. He joined Microvision in 1999 as Controller and has most recently served as Vice President, Accounting and Chief Accounting Officer. Mr. Wilson has been responsible for overseeing the accounting operations and financial reporting of the Company. He has also been responsible for implementing critical Sarbanes Oxley related processes. Prior to joining Microvision, Mr. Wilson served in various accounting positions for Siemens Medical Systems, Inc., a developer and manufacturer of medical imaging equipment. Mr. Wilson, a certified Public Accountant, began his career with the accounting firm PricewaterhouseCoopers LLP. Mr. Wilson holds a B.S. in Accounting from Oklahoma State University.

"Jeff is a seasoned financial executive who possesses the necessary skills to lead this critical function, and to take on an expanded role in the Company's financing and investor relations efforts. He has built a very talented finance team and we are counting on him to help lead the Company's turnaround efforts which include hitting the 30% net burn rate reduction target set earlier this year," said Tokman. "The addition of Sid and Jeff completes the last step of our organizational restructuring and realignment plan and our senior management team is now fully in place."

About Microvision: www.microvision.com.

Headquartered in Redmond, Wash., Microvision, Inc. is the world leader in the development of high-resolution displays and imaging systems based on the company's proprietary silicon micro-mirror technology. The company's technology enables solutions and products in a broad range of industrial, consumer, military, and medical applications.

Forward-Looking Statements

Certain statements contained in this release relating turnaround efforts, burn rate reduction, and product applications are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: our ability to obtain financing; success of executive transition; market acceptance of our technologies and products; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including in its Annual Report on Form 10-K, as may be amended, and its Quarterly Reports on Form 10-Q.